1 The haemodynamic effects of calcium antagonists could depend at leas
t in part on the activity of vasoactive prostanoids. 2 We set out to s
tudy the effect of the cyclo-oxygenase inhibitor ibuprofen, 400 mg thr
ee times daily for 3 days, by a randomised cross-over study vs placebo
in 12 mild to moderate essential hypertensive patients who had been t
reated for 1 month with amlodipine. 3 Blood pressure, heart rate and v
ascular resistances in the upper limb (Doppler ultrasound) were measur
ed. Plasma renin activity and urinary aldosterone, as well as indices
of renal function, were evaluated. Urinary 2,3-dinor-6-keto-PGF(1 alph
a) and 2,3-dinor-TXB(2), as well as 6-keto-PGF(1 alpha) and TXB(2), we
re measured as indices of systemic and renal PGI(2) and TXA(2) synthes
is. 4 Amlodipine normalised blood pressure and reduced upper limb vasc
ular resistances; it did not affect urinary prostanoid excretion. Shor
t-term combined administration of ibuprofen resulted in, by comparison
with placebo, inhibition of systemic PGI(2) (-80.5 ng 24 h(-1), 95% C
I -99.2, -61.4; P < 0.001) and TXA(2) (-216.1 ng 24 h(-1), 95% CI -276
.5, -155.8; P < 0.001), together with an increase in systolic (+7.8 mm
Hg, 95% CI +3.1, +12.3; P < 0.01) and diastolic (+3.9 mm Hg, 95% CI 1.2, +6.6; P < 0.01) blood pressure; it had no significant effect on r
egional vascular resistances (+4.7 mm Hg ml(-1) s, 95% CI -5.6, +15.0)
. Effects of ibuprofen on renal prostanoid synthesis were less marked,
and there was no change in indices of renal function or hydro-electro
lytic balance.5 The haemodynamic effects of amlodipine may be partiall
y antagonised by ibuprofen, which mainly determines inhibition of extr
arenal prostanoid synthesis. It is suggested that this antagonism is a
ttributable not so much to a direct effect of the calcium antagonist o
n prostacyclin synthesis as to an alteration in vascular tone, depende
nt on prostacyclin and perhaps other vasodilatory prostanoids.